Case Study: How to Correct an Unexpectedly Difficult GMP Inspection and Prevent a Relapse
September 20, 2018
One of our clients received an FDA 483 report following an inspection of a European manufacturing facility with significant nonconformances identified, many associated with QC data trails and data integrity. Learn how NSF helped this client avoid a warning letter (through a combination of audit, consultancy and education) and changed the behaviors and mindset that led to the nonconformances.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Annual Review and Impact Report 2025 Now Live
April 20, 2026NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
Visit NSF at Making Pharma 2026
April 10, 2026Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.